For research purposes only. Not for human consumption. Not medical advice.
Semaglutide
Price updated daily
Weight Loss & Metabolic Health
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes (Ozempic) and approved for chronic weight management (Wegovy). It reduces appetite, slows gastric emptying, and improves insulin sensitivity, leading to significant and sustained weight loss. It is the most clinically validated peptide for obesity management.
Research Use Cases
- Significant weight loss
- Type 2 diabetes management
- Cardiovascular risk reduction
- Appetite and food noise reduction
Note: Common GI side effects. Requires gradual titration. Prescription required.